Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
Beteiligte Einrichtungen
Abstract
We report on liver transplantation in two patients with GSD Ib on treatment with empagliflozin. The use of this SGLT2 inhibitor resulted in a marked decrease of 1,5-anhydroglucitol which has an important role in the development of neutropenia in this condition. As intended, this caused a significant rise of neutrophil numbers. Liver transplantation alone did not produce the desired effect and our observation argues for continuing SGLT2 inhibitor treatment after transplantation.
Bibliografische Daten
Originalsprache | Englisch |
---|---|
ISSN | 2214-4269 |
DOIs | |
Status | Veröffentlicht - 06.2023 |
Anmerkungen des Dekanats
© 2023 The Authors.
PubMed | 37275680 |
---|